Introduction
In Latin-American countries, chicken is one of most consumed foods because of its easiness for getting it, its low price, its high protein content, and low lipid content, it is the second favorite meat1. Poultry production increases every year, that is why additives as antibiotics have been employed to encourage upbringing conditions, these additives increase deficiencies in gut microbiota composition. When chickens are born their small intestine is immature and requires morphological, biochemical, and molecular changes that occur during the first two weeks of life, as the animal grows, it is established a microbial community which is more complex through the time. Antibiotics consummation causes digestive disorders be more frequent and produces a low natural resistance to colonization by pathogen microorganisms2,3. Antibiotics residue can reach the consumer through the food chain causing allergic reactions, bacterial resistance and microflora alteration. In different countries, there are difficulties in commercialization due to a breach in the established rules related to substances concentrations presented in the food. Likewise, several studies have been developed in which bacterial pathogens are referred, including resistant isolations, can be transmitted from chicken to humans4.
In general, antibiotics haven’t been used as growing promoters in animals’ diets around the world during decades. This fact has caused a great concern since human health can be affected when generating bacterial resistance; because antibiotics used for infections treatments in humans are employed. Beta lactam antibiotics and fluoroquinolones are broad-spectrum agents commonly used for treating infections, the resistance to this type of antimicrobials has easily arisen. The last reports have demonstrated that resistance to this kind of antibiotics can lead several impacts, which depend on the bacterial strains5. Some countries present a restricted use of antibiotics as growing promoters, for instance Sweden since 1986, Finland since 19956, the European Union since January first 20067; among others. In Colombia the use of antibiotics is regulated by different resolutions and decrees, however, there are not restrictions in antibiotics commercialization for veterinary use; for what in some cases, provision is empirical and with no specialized prescription8. They can be caused by mutations in chromosomal genes and the presence of conjugative and non-conjugative plasmids in the genes9. The objective of this article was to establish resistance profiles and the genes which codify it.
Material and methods
From 200 production chickens, samples were taken with a sterile swab from different organs (trachea, intestines, deep and superficial air-abdominal sacs, pericardium, manufacturing bag, intestine, intestinal contents and pancreas), they were sown in BHI broth and incubated at 37 °C for 24 h, later it was seeded on Mac Conkey agar and incubated at 37 °C for 24 h, they were isolated 35 Escherichia coli strains with extended-spectrum beta-lactamase (ESBL) resistance phenotype of healthy broiler chickens from farms in Santander (Colombia); it was made the microbiological confirmation of gender and species by using BBL Crystal® system and sensitivity tests by means of Kirby Bauer method following CLSI guidelines (2017), using Klebsiella pneumoniae ATCC 700603 strain as positive control and Escherichia coli ATCC 25922 strain as negative control. The susceptibility disks employed were ceftriaxone (CRO 30 µg)(Oxoid ®), cefotaxime (CTX 30 µg) (Oxoid ®), cefepime (FEP 30 µg) (Oxoid ®), nalidixic acid (FEP 30 µg) (Oxoid ®), ciprofloxacin (CIP 1 µg) (Oxoid ®), norfloxacin (NOR 2 µg) (Oxoid ®), piperacillin (PRL 30 µg) (Oxoid ®), aztreonam (ATM 30 µg) (Oxoid ®) and amoxicillin/clavulanic acid (AMC 30 µg) (Oxoid ®). The strains were cultivated in Brain Heart Infusion (BHI) to 37 °C all the night in stirring to make the DNA extraction according to the manufacturer's instructions (Wizard® Genomic DNA Purification Kit), they were considered ideal strains in concentration ≥100μg/μL and DNA-proteins relation A260/280 to determine optimal purity with an OD rate between 1.8 to 2.0 (MaestroNano Micro-Volume Spectrophotometer). They were identified by endpoint PCR blaTEM genes (700 pb), blaSHV genes (700 pb), blaCTX genes (500 pb) and Amp-C genes (550 pb) with the protocole modified by López et al10; and qnrA genes (580 pb), qnrB genes (264 pb), qnrC genes (428 pb) with Aguilar et al protocole 11. The amplified products were visualized by electrophoresis in agarose gel to 1% with TAE to 1% and Safeview classic as a colorant. Gels were visualized by using Ultra Slim Led Illuminator.
Results
Susceptibility profiles were 63 % (n=22/35) for ceftriaxone (Oxoid ®), 69 % (n= 23/35) cefepime (Oxoid ®), 77 % (n =27/35) cefotaxime (Oxoid ®), 86 % (n= 30/35) norfloxacin (Oxoid ®), 89 % (n =31/35) ciprofloxacin (Oxoid ®), 91 % (n =32/35) piperacillin (Oxoid ®), 91 % (n =32/35) aztrenam (Oxoid ®), 97 % (n =34/35) amoxicillin/clavulanic acid (Oxoid ®) and 97 % (n=34/35) nalidixic acid (Oxoid ®). Regarding antibiotics groups it was presented E.coli 70 % of resistance to cefalosporines, 90 % to quinolones and 93 % to beta lactams (Figure 1). Regarding genes, they were identified fragments of the expected size, for the genes which codify for beta lactamase resistance it was identified 83 % of AmpC gene, 86 % of blaCTXM gene, 54 % of blaSHV gene and 57 % of blaTEM gene (Figure 2). Regarding genes which codify for quinolone resistance, it was identified 94 % of qnrB gene, 9 % of qnrC gene and 0 % of qnrA gene (Figure 2 and Table 1).
1= 1Kb, C2= Positive control, C3= Mx1, C4= Mx2, C5=Mx3, C6= Mx4, C7= Mx5, C8=Mx6, C9= Mx7, C10= Mx8, C11= Mx9, C12= Mx10, C13= Mx11, C14= negative control.
Sample | Ampc | blaCTX-M | blaSHV | blaTEM | qnrA | qnrB | qnrS | CRO | CTX | FEP | AMC | CIP | NOR | PRL | ATM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | P | P | P | P | N | N | N | R | I | I | R | R | S | I | I |
2 | P | P | N | P | N | N | N | I | R | S | R | I | I | R | R |
3 | P | P | P | P | N | P | P | R | R | R | R | R | R | R | R |
4 | N | N | N | N | N | P | P | S | I | S | R | R | R | R | R |
5 | P | P | P | N | N | P | N | R | R | R | R | R | R | R | R |
6 | P | P | P | P | N | P | N | R | I | R | R | I | I | R | R |
7 | P | P | P | N | N | P | N | S | I | S | R | R | R | R | R |
8 | P | P | N | P | N | P | N | R | R | R | R | R | R | R | R |
9 | P | P | N | P | N | P | N | R | R | R | R | R | R | R | R |
10 | N | N | P | N | N | P | N | R | R | R | R | R | R | R | R |
11 | P | N | N | P | N | P | N | I | R | I | R | R | I | R | I |
12 | P | P | N | P | N | P | N | S | S | S | R | I | R | R | R |
13 | P | P | P | N | N | P | N | I | R | R | R | R | R | R | R |
14 | P | P | N | P | N | P | N | R | R | R | R | R | R | R | R |
15 | P | P | P | N | N | P | N | R | R | I | R | R | R | R | R |
16 | P | N | N | P | N | P | N | S | S | S | R | R | R | R | R |
17 | P | P | N | N | N | P | N | S | S | S | R | R | R | I | R |
18 | P | P | P | N | N | P | N | I | R | I | R | R | R | R | R |
19 | P | P | P | N | N | P | N | S | R | R | R | R | R | R | R |
20 | P | P | P | P | N | P | P | R | R | R | R | R | R | R | R |
21 | P | P | P | N | N | P | N | R | R | R | R | R | R | R | R |
22 | P | N | P | N | N | P | N | S | S | S | R | R | R | R | R |
23 | P | P | N | N | N | P | N | R | R | R | R | R | R | R | R |
24 | P | P | P | P | N | P | N | R | R | R | R | R | R | R | R |
25 | P | P | P | P | N | P | N | R | R | R | R | R | R | R | R |
26 | P | P | N | P | N | P | N | R | R | R | R | R | R | R | R |
27 | N | N | N | N | N | P | N | R | R | R | R | R | R | R | R |
28 | P | P | P | P | N | P | N | R | R | R | R | R | R | R | R |
29 | P | P | N | P | N | P | N | R | R | R | R | R | R | R | R |
30 | P | P | P | P | N | P | N | R | R | R | R | R | R | R | R |
31 | N | N | N | N | N | P | N | I | R | R | R | R | R | R | R |
32 | P | P | N | P | N | P | N | S | R | R | R | R | R | R | R |
33 | N | P | P | P | N | P | N | R | R | R | R | R | R | R | R |
34 | P | P | P | P | N | P | N | R | R | R | R | R | R | R | R |
35 | N | N | N | N | N | P | N | R | R | R | R | R | R | R | R |
P= positive; N= negative; R= resistant; S= sensitive; I= intermediate.
CRO= ceftriaxone; CTX= cefotaxime; FEP= cefepime; AMC= amoxycillin/clavulanic acid. CIP= ciprofloxacin; NOR= norfloxacin; PRL= piperacillin; ATM= aztreonam.
Discussion
From susceptibility profiles, it can be noticed the strains presented multiresistence, taking into account that these ones had resistance to more than four antibiotics; 49 % presented resistance to all the antibiotics, these results generate a great concern. In South Korea, they found resistance to even eleven antibiotics, including ciprofloxacin12. Yurong et al obtained similar results when finding resistance to more than five antimicrobial agents; in which, ciprofloxacin and levofloxacine stand out13. Regarding antibiotic groups, it excels that 93 % presented resistance to beta-lactams, followed by quinolones in 90 % and cephalosporins in 70 % (Figure 3); antimicrobials which are employed for daily use of bacterial infections in humans. Similar reports were made in Korea with resistance to ampicilin (75 %), followed by tetracycline (69 %) and ciprofloxacin (65 %)14. While Varga et al15 identified resistance to beta-lactams, sulfonamides and tetracyclines in poultry. In Colombia, bacteria resistant to multiple drugs such as ceftiofur, enrofloxacin, nalidixic acid and tetracycline, were isolated from the meat of poultry from independent stores and from a distribution center of the main chain, which generates an alarm for the health entities of the country16.
Within resistance it is necessary to confirm the phenotypes of resistance by means of PCR identifying the genes which codify it, for beta-lactamases they can be found the next genes blaTEM, blaSHV , blaCTX and Amp-C17; and for fluoroquinolones the genes are qnrA , qnrB and qnrC11; from the profiles previously analyzed, it can be noticed similarity to what other authors reported. Researches made in Brazil, exposed that the isolations which present the genes blaCTX-M-2 or blaCMY-2 tend to accumulate resistance to a higher rate of non-betalactamic antimicrobials4. In China, the genes which predominated in isolations were blaCTXM and blaTEM, likewise they found variants of blaCMY; as long as blaSHV was not identified13; as well as in studies made in Pakistan18, while for the current research, it was presented in a 57 %. Alonso et.al refer that the dissemination of blaSHV can occur by horizontal transfer, mainly caused by plasmids, which could facilitate the dissemination of this gene19. Regarding AmpC, in the United Kingdom, they were analyzed imported chicken finding un 23 % of this gene, as well as they were identified mutations of this one20. However, in countries like Ecuador they obtained a high prevalence of the blaCTXM gene, results that differ from those obtained in the study21.
The use of antibiotics as growing promoters in animals generates a great concern due to a spreading of resistant bacteria, since chicken has an easy commercialization. In the present study it is noticed that 26 % of the strains presented the four genes, 46 % three genes, 14 % two genes, 3 % one gene and 4 % no gene; Molecular biology techniques have a great relevance, because through them, they are confirmed the resistance phenotypes by punctual mutations in the target genes in susceptible bacteria22.
The qnr genes are mediated by plasmids, transmissible by conjugation that relates to their potential for circulation. The primer has been reported in 1998 and since then five types of qnr genes (qnrA, qnrB, qnrS, qnrC, and qnrD) have been reported, containing more than 30 alleles23. The animals can act as reservoirs for a series of zoonotic infections, which can be transmitted to humans by direct contact or through the food chain24. Kilani et al in animal samples, 17.6 % identified qnr-type genes, as well as genes for beta-lactamases, which is why it is similar to what was identified in the present study25. Clemente et al detected in E. coli isolations the gene gyrA in food producer animals which expressed in a whole the gene blaCMY-226. In the research made by Montes et al they reported only 1 % of the gene gyrB and the gene gyrA 0%11, while in Quito, 36 % of isolations of Broiler chicken in a poultry the gene qnrB. Results similar to those reported in Brazil, in which they were able to identify variants of the gyr gene in isolates from food and humans, observing a reduced susceptibility to ciprofloxacin27. The results obtained in the present research about the presence of genes which codify for resistance to quinolines is high regarding the other researches made by other authors, different studies have found that genes qnr are highly distributed in E. coli isolated of healthy humans, domestic and farm animals9.
Conclusions and implications
The coexistence of genes which codify for antibiotics resistance is a serious problem that requires vigilance. In light of this situation they must generate control strategies to avoid spreading through food chain, since chicken is one of the most available foods within market basket. These results reflect the resistance found mainly for antimicrobials that act by inhibiting wall synthesis and protein synthesis, such as cephalosporins and gentamicin respectively, showing evidence of the theory of the production of extended-spectrum beta-lactamases mechanism that may be plasmid mediated, which represents an emerging resistance problem. The limitations of this study include a sampling bias, since only one farm was worked, in addition to having no stool samples. Therefore, this study could overestimate the frequency of resistance by samples coming from birds that may have already been treated with antimicrobials.